Weekly Legislative Roundup 4/12/19 – NORML Blog

by Carly Wolf, NORML State Policies CoordinatorApril 12, 2019

Welcome to the latest edition of NORML’s Weekly Legislative Roundup!

At the state level, a bill to allow licensed social consumption spaces in Oregon was defeated for this year.

A bill to allow patients to use medical cannabis while on probation or parole died in Montana’s state Senate.

At a more local level, the city council of New York City approved a pair of municipal bills this week limiting situations where those seeking employment or on probation may be drug tested for past cannabis use.

Following are the bills that we’ve tracked this week and as always, check NORML’s Action Center for legislation pending in your state.

Don’t forget to sign up for our email list, and we will keep you posted as these bills and more move through your home state legislature and U.S. Congress. Another great way to stay up to date is Marijuana Moment’s daily newsletter, which you can subscribe to HERE.

Your Highness,
Carly

Actions to Take

Federal

End Prohibition: The Marijuana Justice Act would (1) remove marijuana from the US Controlled Substances Act, thereby ending the federal criminalization of cannabis; (2) incentivize states to mitigate existing and ongoing racial disparities in state-level marijuana arrests; (3) expunge federal convictions specific to marijuana possession; (4) allow individuals currently serving time in federal prison for marijuana-related violations to petition the court for resentencing; (5) and create a community reinvestment fund to invest in communities most impacted by the failed War on Drugs.

Send a message to your federal lawmakers in support of this important legislation

Colorado

Legislation is pending, House Bill 19-1230, to allow the social consumption of cannabis by adults in licensed and regulated establishments.

The measure would establish a license permit process for hospitality spaces to allow cannabis products to be legally purchased and

Read More Here...

Leave a Comment

Please Rate This Content*

Your email address will not be published. Required fields are marked *